Tone mix
Week by week 52 weeks
Share of Nurix Therapeutics, Inc. Common stock's 144 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Apr 27, 2026 · tone +100Nurix Therapeutics Inc. (NRIX): Leadership in Targeted Protein Degradation Attracts Smart Money+90
- Week of Apr 28, 2025 · tone +100Nurix Therapeutics' (NRIX) Buy Rating Reiterated at Needham & Company LLC+80
- Week of Oct 5, 2026 · tone +100Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock Rated "Moderate Buy" by Wall Street Brokerages+78
- Week of Sep 28, 2026 · tone +100Nurix Therapeutics Announces Achievement of $7 Million Milestone Under Strategic Collaboration with Pfizer+74
- Week of Jul 6, 2026 · tone -25Needham & Company LLC Reiterates Buy Rating for Nurix Therapeutics (NASDAQ:NRIX)-72
- Week of Aug 10, 2026 · tone +87Nurix Therapeutics (NASDAQ:NRIX) Hits New 1-Year High Following Analyst Upgrade+68
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Nurix Therapeutics, Inc. Common stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 0 | No headlines |
| Last 30 sessions | 11 | +45 |
| Last 90 sessions | 36 | +21 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Monday, October 19, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletNurix Therapeutics (NASDAQ:NRIX) Director Sells $528,442.20 in StockNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nurix Therapeutics (NASDAQ:NRIX) Director Sells $528,442.20 in Stock | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
3 headlines, average tone +66: 2 positive, 1 neutral and 0 negative. Showing all 3.
- www.tickerreport.com · 1 outletNurix Therapeutics (NASDAQ:NRIX) Stock Price Up 4.1% After Analyst UpgradePositive
- www.dailypolitical.com · 1 outletNurix Therapeutics (NASDAQ:NRIX) Shares Climb 4.1% After Analyst UpgradePositive
- www.dailypolitical.com · 1 outletNurix Therapeutics (NASDAQ:NRIX) Director Julia Gregory Sells 22,583 Shares of Company StockNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nurix Therapeutics (NASDAQ:NRIX) Stock Price Up 4.1% After Analyst Upgrade | www.tickerreport.com | 1 | Positive |
| Nurix Therapeutics (NASDAQ:NRIX) Shares Climb 4.1% After Analyst Upgrade | www.dailypolitical.com | 1 | Positive |
| Nurix Therapeutics (NASDAQ:NRIX) Director Julia Gregory Sells 22,583 Shares of Company Stock | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 14, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletNurix Therapeutics (NASDAQ:NRIX) Posts Earnings ResultsNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nurix Therapeutics (NASDAQ:NRIX) Posts Earnings Results | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 13, 2026
3 headlines, average tone 0: 0 positive, 3 neutral and 0 negative. Showing all 3.
- www.sci-tech-today.com · 1 outletNurix Therapeutics Q3 2026 Earnings: Key Financials RevealedNeutral
- www.manilatimes.net · 1 outletNurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate UpdateNeutral
- www.tickerreport.com · 1 outletNurix Therapeutics (NASDAQ:NRIX) Releases Earnings ResultsNeutral
Show the table · 3 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nurix Therapeutics Q3 2026 Earnings: Key Financials Revealed | www.sci-tech-today.com | 1 | Neutral |
| Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update | www.manilatimes.net | 1 | Neutral |
| Nurix Therapeutics (NASDAQ:NRIX) Releases Earnings Results | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 7, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletNurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic LeukemiaPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Nurix Therapeutics Announces First Patient Enrolled in Phase 1b/2 Combination Study of Bexobrutideg in Chronic Lymphocytic Leukemia | www.manilatimes.net | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Nurix Therapeutics, Inc. Common stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.